MedPath

Vitamin C with levothyroxine in primary hypothyroidism

Not Applicable
Recruiting
Conditions
Hypothyroidism.
Registration Number
IRCT20180220038807N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
189
Inclusion Criteria

The age of 18 to 75 years of both sexes is male and female
The level of patient's TSH when entering the study is between 0.5 and 4.5 Miu / l
At least six months, the patient's dose of levothyroxine has not changed

Exclusion Criteria

Patients with thyroid cancer, chronic gastrointestinal diseases, celiac disease, lactose intolerance, intestinal infections (Giardia lamblia), chronic lung, kidney and liver disease (cirrhosis), kidney stones, or history of kidney stones, CHF, vitamin B12 deficiency, pancreatic insufficiency As well as patients with jejunostyle or jejunoileal bypass, suffering from short-systolic syndrome or autoimmune gasteritis and H.Pylori infection
Pregnant, lactating and purpose to pregnancy women
Hormone-treated patients, such as taking contraceptives or estrogen and testosterone over the past three months
Patients treated with any of the following drugs or compounds: ferrous sulfate, calcium carbonate, colestipol, aluminum hydroxide, sucralfate, propranolol, laxatives, levostatin, solvate ester (sevelamer), cromium picolinate, bile acid sequestrants Gastric acid antacids, sucralfate, sodium polysterone sulfonate, cholesterol, dopamine analogues, steroids, somatostatin and also anticonvulsants, raloxifene, cimetidine, amiodarone, sertraline and activated charcoal.
Patients who have a change in their TSH for more than 1 unit in the first 8 weeks of their study or who have complications of vitamin C (severe nausea and vomiting or severe diarrhea)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thyroid function test levels. Timepoint: Before and 8 weeks after intervention. Method of measurement: By measuring serum levels of TSH and T4.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath